Skip to main content
Premium Trial:

Request an Annual Quote

AstraZeneca Sponsors Fellow to Develop Cancer Assays at UK's DxS

NEW YORK  (GenomeWeb News) - AstraZeneca and the University of Manchester are placing a Clinical Research Fellow at DxS to work on a project to identify circulating DNA tumor markers in blood.
 
The focus of the three-year project will initially be to develop assays for genes that show prevalent mutations in cancer.  It is supported by AstraZeneca and Cancer Research UK.
 
DxS will help the fellow, unnamed in a press release, to develop the assays using the company's Scorpions and ARMS technologies.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.